版本:
中国

BRIEF-KaloBios receives $5.5 mln in new financing from existing investors

March 23 KaloBios Pharmaceuticals Inc -

* KaloBios receives $5.5 mln in new financing from existing investors

* Says amendment brings total principal amount of loan from lenders to $9.2 million

* Proceeds from financing to provide additional working capital to co, support ongoing development of benznidazole for potential U.S. Approval Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐